Association of functional-509C>T polymorphism in the TGF-β1 gene with infiltrating ductal breast carcinoma risk in a Russian Western Siberian population

被引:6
作者
Babyshkina, Nataliya [1 ]
Malinovskaya, Elena [1 ]
Stakheyeva, Marina [1 ]
Volkomorov, Victor [1 ]
Slonimskaya, Elena [2 ]
Maximov, Vladimir [3 ]
Cherdyntseva, Nadejda [1 ]
机构
[1] Russian Acad Med Sci, Siberian Branch, Canc Res Inst, Dept Expt Oncol, Tomsk 634001, Russia
[2] Russian Acad Med Sci, Siberian Branch, Canc Res Inst, Dept Gen Oncol, Tomsk 634001, Russia
[3] Russian Acad Med Sci, Inst Internal Med, Siberian Branch, Novosibirsk, Russia
关键词
TGF-beta; 1; Polymorphism; Infiltrating ductal breast carcinoma; Risk; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CANCER RISK; TRANSFORMING-GROWTH-FACTOR-BETA-1; SURVIVAL; DISEASE; TGFB1;
D O I
10.1016/j.canep.2011.02.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Transforming growth factor beta 1 (TGF-beta 1) is a multifunctional cytokine that plays an important role in human mammary carcinogenesis. The purpose of this study was to investigate the association between -509C>T single nucleotide polymorphism (SNP) of the TGF-beta 1 gene and infiltrating ductal breast carcinoma risk in Russian patients of Western Siberian region. Materials and methods: Blood samples collected from 218 women with histologically confirmed infiltrating ductal breast carcinoma and 290 healthy female controls were analyzed through polymerase chain reaction-restriction fragment length polymorphism methods. Results: The -509TT genotype was significantly associated with a decreased risk for ductal breast carcinoma (OR = 0.47, CI: 0.26-0.82, P = 0.004). Similarly, the -509T was significantly less in ductal breast cancer patients (34.4%) than in control individuals (41.6%; OR = 0.74, CI: 0.57-0.96, P = 0.02). With the exception of association between the -509TT genotype and large tumor size (P = 0.01), there was no significant association between the studied polymorphism and clinicopathological characteristics. Conclusion: The results of this study suggest that polymorphism of TGF-beta 1 -509C>T gene may modify individual susceptibility to infiltrating ductal breast carcinoma in Russian women of Western Siberian region. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:560 / 563
页数:4
相关论文
共 33 条
[1]   Transforming growth factor-β and breast cancer -: Mammary gland development [J].
Barcellos-Hoff, MH ;
Ewan, KBR .
BREAST CANCER RESEARCH, 2000, 2 (02) :92-99
[2]   Role of transforming growth factor β in breast carcinogenesis [J].
Benson, JR .
LANCET ONCOLOGY, 2004, 5 (04) :229-239
[3]   Inhibition of transforming growth factor-β signaling in human cancer:: Targeting a tumor suppressor network as a therapeutic strategy [J].
Biswas, Swati ;
Criswell, Tracy L. ;
Wang, Shizhen Emily ;
Arteaga, Carlos L. .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4142-4146
[4]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[5]   Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure - The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study [J].
Cambien, F ;
Ricard, S ;
Troesch, A ;
Mallet, C ;
Generenaz, L ;
Evans, A ;
Arveiler, D ;
Luc, G ;
Ruidavets, JB ;
Poirier, O .
HYPERTENSION, 1996, 28 (05) :881-887
[6]   TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study [J].
Cox, David G. ;
Penney, Kathryn ;
Guo, Qun ;
Hankinson, Susan E. ;
Hunter, David J. .
BMC CANCER, 2007, 7 (1)
[7]   Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival [J].
Desruisseau, S ;
Palmari, J ;
Giusti, C ;
Romain, S ;
Martin, PM ;
Berthois, Y .
BRITISH JOURNAL OF CANCER, 2006, 94 (02) :239-246
[8]  
Dunning AM, 2003, CANCER RES, V63, P2610
[9]   Role of transforming growth factor beta in human cancer [J].
Elliott, RL ;
Blobe, GC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :2078-2093
[10]  
Elston C.W., 1998, BREASTSYSTEMIC PATHO, V13, P239